Belgium· BE-AMP-SAM526391-00
Dopaview 222 MBq/ml
A fluorodopa (18f) product containing fluorodopa (18 f), registered in Belgium by Advanced Accelerator Applications. The same ATC class is registered in 6 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Fluorodopa (18f) is registered in 6 of 19 countries.
Countries holding a registration under ATC V09IX05 (fluorodopa (18f)), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 4 of them publish a price we can compare per daily dose
Fluorodopa (18f) · ATC V09IX05
6 / 19 countries
- Belgiumprice
- Czechiaprice
- Germany
- Netherlands
- Spainprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Fluorodopa (18 F)
- Manufacturer
- Advanced Accelerator Applications
- Country
- Belgium (BE)
- ATC code
- V09IX05
- ATC class
- Fluorodopa (18F)
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V09IX05
Fluorodopa (18f), as other registers publish it.
- SpainDOPACIS 90 MBq/ml SOLUCION INYECTABLECis Bio International
- NetherlandsDopacis 90 MBq/ml, oplossing voor injectieCis Bio International
- GermanyDoparosHelmholtz-Zentrum Dresden-Rossendorf Fwp
- GermanyDopaviewAdvanced Accelerator Applications Molecular Imaging France S.A.S.
- SpainDOPAVIEW 222 MBQ/ML SOLUCION INYECTABLEAdvanced Accelerator Applications Molecular Imaging France
- SwitzerlandDopaview 222 MBq/ml, InjektionslösungSiemens Healthineers Radiopharma CH GmbH
- CzechiaFLUORODOPA (18F) BIONTBIONT a.s., Bratislava
- CzechiaFLUORODOPA (18F) UJVÚJV Řež a.s., Husinec - Řež
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c3b491bb-6350-4b19-a231-e9c98bd2f280 GET /v1/drugs/c3b491bb-6350-4b19-a231-e9c98bd2f280?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"source": "afmps",
"status": "REVOKED",
"name_en": "Dopaview 222 MBq/ml",
"name_fr": "Dopaview 222 MBq/ml",
"name_nl": "Dopaview 222 MBq/ml",
"amp_code": "SAM526391-00",
"strengths": [
"222.0000",
"222.0000",
"0.0340",
"9.0000"
],
"pack_count": 1,
"substances": [
"Fluorodopa (18 F)",
"Sodium Acetate",
"Sodium Chloride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Fluorodopa (18f)",
"authorisation_numbers": [
"BE526391"
]
}See everything about fluorodopa (18f).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.